RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Alveolar Bone Loss
Accession: DOID:9000927
browse the term
Definition: Resorption or wasting of the tooth-supporting bone (ALVEOLAR PROCESS) in the MAXILLA or MANDIBLE.
Synonyms: exact_synonym: Alveolar Bone Atrophies; Alveolar Bone Atrophy; Alveolar Bone Losses; Alveolar Process Atrophies; Alveolar Process Atrophy; Alveolar Resorption; Alveolar Resorptions; Periodontal Bone Loss; Periodontal Bone Losses; Periodontal Resorption; Periodontal Resorptions
primary_id: MESH:D016301 ; RDO:0006950
G
Ace2
angiotensin converting enzyme 2
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acp5
acid phosphatase 5, tartrate resistant
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Agtr1a
angiotensin II receptor, type 1a
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agtr2
angiotensin II receptor, type 2
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Alpl
alkaline phosphatase, biomineralization associated
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism associated with hypertension, periodontal disease
CTD RGD
PMID:20630305 PMID:33364953
RGD:329956421
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Ccr2
C-C motif chemokine receptor 2
ISO
associated with Periodontitis;
RGD
PMID:21241302
RGD:8661687
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ctsk
cathepsin K
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cxcl3
C-X-C motif chemokine ligand 3
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Il10
interleukin 10
treatment
IEP
associated with Diabetes Mellitus, Experimental associated with periodontal disease
RGD
PMID:26270535 PMID:33364953
RGD:11049527 , RGD:329956421
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itgav
integrin subunit alpha V
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Mmp2
matrix metallopeptidase 2
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Oscar
osteoclast associated Ig-like receptor
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 1:65,607,214...65,615,395
Ensembl chr 1:65,607,410...65,613,758
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
RGD
PMID:14630900
RGD:10413909
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pparg
peroxisome proliferator-activated receptor gamma
treatment
IEP
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Tnf
tumor necrosis factor
treatment
IEP
associated with Diabetes Mellitus, Experimental associated with periodontal disease
RGD
PMID:26270535 PMID:33364953
RGD:11049527 , RGD:329956421
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11a
TNF receptor superfamily member 11A
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf11b
TNF receptor superfamily member 11B
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfsf11
TNF superfamily member 11
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism associated with periodontal disease
CTD RGD
PMID:19249596 PMID:33364953
RGD:329956421
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Vtn
vitronectin
treatment
IEP
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all